Ombitasvir
| CAS No. | 1258226-87-7 |
|---|---|
| MDL No. | N/A |
| MF | C50H67N7O8 |
| MW | 894.10 |
| InChI Key | PIDFDZJZLOTZTM-KHVQSSSXSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ombitasvir is a dipeptide derivative used in combination with dasabuvir sodium hydrate, paritaprevir, and ritonavir (Viekira Pak) for treating chronic hepatitis C virus genotype 1 infection and liver cirrhosis. It functions as an antiviral drug and hepatitis C virus nonstructural protein 5A inhibitor. It belongs to pyrrolidines, carbamate esters, aromatic amides, and dipeptides, and is functionally related to Val-Pro.
| CAS No. | 1258226-87-7 |
|---|---|
| Product Name | Ombitasvir |
| Heavy Atom Count | 65 | Rotatable Bond Count | 13 |
| Atom Stereo Count | 6 | Bond Stereo Count | 0 |
| HBA | 9 | HBD | 4 |
| TPSA | 178.720 Ų | Charge | 0 |
| Exact Mass | 893.50511 | Complexity | 2045.02 |
| pKa | 5.875 | XLogP | 7.687 |